Rachelle Suzanne Jacques's Net Worth

$3.76 Billion

Estimate Recalculated Sep 18, 2024 03:41PM EST

Who is Rachelle Suzanne Jacques?

Rachelle Suzanne Jacques has an estimated net worth of $3.76 Billion. This is based on reported shares across multiple companies, which include uniQure N.V., Viela Bio, Inc., Corbus Pharmaceuticals Holdings, Inc., and Akari Therapeutics Plc.

SEC CIK

Rachelle Suzanne Jacques's CIK is 0001772610

Past Insider Trading and Trends

2022 was Rachelle Suzanne Jacques's most active year for acquiring shares with 5 total transactions. Rachelle Suzanne Jacques's most active month to acquire stocks was the month of May. 2021 was Rachelle Suzanne Jacques's most active year for disposing of shares, totalling 2 transactions. Rachelle Suzanne Jacques's most active month to dispose stocks was the month of February. 2024 saw Rachelle Suzanne Jacques paying a total of $0.00 for 479,599,378 shares, this is the most they've acquired in one year. In 2023 Rachelle Suzanne Jacques cashed out on 2,685 shares for a total of $50,854.44, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

uniQure N.V. (QURE) Snapshot price: $5.42

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+56.08%
8.08K
—
—
22.49K
Jun 19
Form 4
-13.36%
-2.22K
$5.14
-$11,415.94
14.41K
Jun 13
Form 4
+62.55%
6.4K
$18.76
-$43,166.76
16.63K
Jun 13 - Jun 16
Form 4
-3.62%
-384.00
$20.02
-$7,687.68
10.23K
Feb 27
Form 4
+591.92%
9.08K
—
—
10.61K
Jun 15
Form 4
∞
1.53K
—
—
1.53K
Feb 24
Form 4
—
0
—
—
0
Oct 21
Form 3
—
0
—
—
0
No matching records found

Viela Bio, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 15
Form 4/A
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 19
Form 3
—
0
—
—
0
No matching records found

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.78K
—
—
2.78K
May 30
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Apr 5
Form 3
—
0
—
—
0
No matching records found

Akari Therapeutics Plc (AKTX) Snapshot price: $3.69

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+89.06%
479.57M
—
—
1.02B
Apr 26
Form 3
—
0
—
—
0
No matching records found